We are live on ! Find out more
B

Bailard Portfolio holdings

AUM $4.35B
1-Year Est. Return 23.57%
This Fund
S&P 500
This Quarter Est. Return
+4.29%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$1.64B
AUM Growth
+$23.5M
Cap. Flow
-$31.1M
Cap. Flow %
-1.9%
Top 10 Hldgs %
31.5%
Holding
630
New
91
Increased
163
Reduced
168
Closed
91

Sector Composition

Rank Sector Weight
1 Technology 14.03%
2 Healthcare 7.09%
3 Financials 4.96%
4 Communication Services 4.91%
5 Industrials 4.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
151
ExxonMobil
XOM
$640B
$2.16M 0.13%
28,245
+52
+0.2% +$4.03K
HCA icon
152
HCA Healthcare
HCA
$82.5B
$2.11M 0.13%
15,594
-1,051
-6% -$133K
TEL icon
153
TE Connectivity
TEL
$58.5B
$2.11M 0.13%
22,006
SUSB icon
154
iShares ESG Aware 1-5 Year USD Corporate Bond ETF
SUSB
$1.29B
$2.1M 0.13%
82,956
+34,126
+70% +$855K
DGX icon
155
Quest Diagnostics
DGX
$23.2B
$2.09M 0.13%
20,565
+882
+4% +$84.8K
NSIT icon
156
Insight Enterprises
NSIT
$3.56B
$2.05M 0.13%
35,200
STLD icon
157
Steel Dynamics
STLD
$34.4B
$2.04M 0.13%
67,718
-2,809
-4% -$85.9K
ICF icon
158
iShares Select U.S. REIT ETF
ICF
$2.08B
$2.04M 0.12%
36,220
+774
+2% +$43.5K
LRCX icon
159
Lam Research
LRCX
$399B
$2.02M 0.12%
107,400
+2,000
+2% +$37.9K
GWRE icon
160
Guidewire Software
GWRE
$11.2B
$1.9M 0.12%
18,749
SYK icon
161
Stryker
SYK
$119B
$1.9M 0.12%
9,219
+57
+0.6% +$10.9K
DBVT
162
DBV Technologies
DBVT
$807M
$1.89M 0.12%
23,000
-11,700
-34% -$1.05M
SGMO
163
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.89M 0.12%
175,600
+19,500
+12% +$207K
BRK.B icon
164
Berkshire Hathaway Class B
BRK.B
$1.06T
$1.87M 0.11%
8,786
+377
+4% +$78K
AZO icon
165
AutoZone
AZO
$48.5B
$1.84M 0.11%
1,678
SCHZ icon
166
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
$1.82M 0.11%
68,614
+24,940
+57% +$649K
IGLB icon
167
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.6B
$1.81M 0.11%
+28,430
New +$1.73M
ESML icon
168
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
$2.85B
$1.81M 0.11%
66,997
+14,195
+27% +$378K
SCHO icon
169
Schwab Short-Term US Treasury ETF
SCHO
$12.7B
$1.8M 0.11%
71,258
+27,184
+62% +$683K
QCOM icon
170
Qualcomm
QCOM
$185B
$1.73M 0.11%
22,751
+1,600
+8% +$117K
CIB icon
171
Grupo Cibest SA
CIB
$20.1B
$1.71M 0.1%
33,479
AZN icon
172
AstraZeneca
AZN
$263B
$1.7M 0.1%
20,630
+2,000
+11% +$157K
VOX icon
173
Vanguard Communication Services ETF
VOX
$5.7B
$1.7M 0.1%
19,552
+1,453
+8% +$126K
ORCL icon
174
Oracle
ORCL
$362B
$1.66M 0.1%
29,139
+169
+0.6% +$9.14K
AMGN icon
175
Amgen
AMGN
$198B
$1.64M 0.1%
8,909
-43
-0.5% -$7.7K

Similar funds

Bailard's Q2 2019 Portfolio in Review

As of Q2 2019, Bailard held 630 positions worth $1.64B, up 1.5% from $1.61B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Bailard's Q2 2019 filing shows 91 new, 163 increased, 168 reduced and 91 closed positions. Its largest new stake was Vanguard Total Bond Market: 687,016 shares worth $57.1M. The largest sale was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, an estimated $58.5M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Financials.

  • Bailard's largest Q2 2019 buy was Vanguard Total Bond Market: 687,016 shares worth $57.1M.
  • Bailard added most to iShares US Real Estate ETF in Q2 2019, an estimated $56.7M increase.
  • Bailard's biggest Q2 2019 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $58.5M.
  • Bailard fully exited Teva Pharmaceuticals in Q2 2019, selling an estimated $5.65M.
  • Bailard's ten largest holdings make up 32% of its $1.64B portfolio in Q2 2019.
  • Bailard opened 91 new positions and closed 91 in Q2 2019.
  • Bailard's portfolio value rose 1.5% quarter-over-quarter to $1.64B.

Based on Bailard's 13F filing for Q2 2019, filed 26 Jul 2019.